Vfend Oral Suspension Generic Name & Formulations
Vfend Oral Suspension Indications
Vfend Oral Suspension Dosage and Administration
Vfend Oral Suspension Contraindications
Vfend Oral Suspension Boxed Warnings
Vfend Oral Suspension Warnings/Precautions
Vfend Oral Suspension Pharmacokinetics
Vfend Oral Suspension Interactions
See Contraindications. Potentiates cyclosporine, tacrolimus, phenytoin, warfarin, methadone, fentanyl, alfentanil, oxycodone, other CYP3A4, CYP2C9, or CYP2C19 substrates (eg, benzodiazepines, vinca alkaloids, statins, omeprazole, ivacaftor, other NNRTIs, HIV protease inhibitors, calcium channel blockers, sulfonylureas, NSAIDs); monitor for adverse reactions; adjust dose as needed. Potentiates, and potentiated by oral contraceptives; monitor. Antagonized by phenobarbital, phenytoin, letermovir, possibly delavirdine, efavirenz 300mg every 24hrs, other CYP3A4 inducers. Concomitant everolimus, fluconazole: not recommended. Avoid concomitant low-dose ritonavir (100mg every 12hrs), lemborexant, glasdegib, tyrosine kinase inhibitors; see full labeling. Monitor for adrenal dysfunction with corticosteroids. IV: do not infuse with concomitant blood product or short-term infusion of concentrated electrolytes. Increased risk of skin toxicity with methotrexate.
Vfend Oral Suspension Adverse Reactions
Visual disturbances, fever, nausea, vomiting, rash, chills, headache, increased LFTs, tachycardia, hallucinations; infusion-related reactions, cutaneous reactions (eg, SJS, TEN, DRESS), photosensitivity (esp. in children), squamous cell carcinoma (during long-term use), renal toxicity, adrenal dysfunction. Children also: epistaxis, abdominal pain, diarrhea, hypertension, thrombocytopenia, hypokalemia, cough, peripheral edema, ALT abnormal, others.
Vfend Oral Suspension Clinical Trials
Vfend Oral Suspension Note
Vfend Oral Suspension Patient Counseling